Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S., Petrie, J., Franek, E., . . . Eriksson, M. (2016). LEADER 5: Prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol.
استشهاد بنمط شيكاغوMasmiquel, L., et al. "LEADER 5: Prevalence and Cardiometabolic Impact of Obesity in Cardiovascular High-risk Patients With Type 2 Diabetes Mellitus: Baseline Global Data From the LEADER Trial." Cardiovasc Diabetol 2016.
MLA استشهادMasmiquel, L., et al. "LEADER 5: Prevalence and Cardiometabolic Impact of Obesity in Cardiovascular High-risk Patients With Type 2 Diabetes Mellitus: Baseline Global Data From the LEADER Trial." Cardiovasc Diabetol 2016.